Sickle-cell-induced hematuria in pregnancy. The current diagnostic and therapeutic approach.
Hematuria is a rather frequent complication in patients with sickling disorders. However, the occurrence, incidence and management of this complication during pregnancy have not been discussed in the medical literature. We treated three patients with sickle-cell-induced hematuria in pregnancy and developed an approach we find useful for such patients.
D000293:Adolescent; D000328:Adult; D000614:Aminocaproates / Q000008:administration & dosage*; D015119:Aminocaproic Acid / Q000008:administration & dosage*; D000755:Anemia, Sickle Cell / Q000150:complications* / Q000628:therapy; D005260:Female; D005440:Fluid Therapy; D006417:Hematuria / Q000209:etiology* / Q000628:therapy; D006801:Humans; D007231:Infant, Newborn; D008297:Male; D011247:Pregnancy; D011250:Pregnancy Complications, Hematologic / Q000628:therapy*
D000614:Aminocaproates; D015119:Aminocaproic Acid